Literature DB >> 28134713

HIV viral load scale-up: multiple interventions to meet the HIV treatment cascade.

Sergio Carmona1, Trevor Peter, Leigh Berrie.   

Abstract

PURPOSE OF REVIEW: In 2015, the WHO urged countries to provide ART to all people living with HIV, irrespective of their CD4 cell count, this new recommendation supports the Joint United Nations Programme on HIV/AIDS elimination targets. However, to meet these aims, urgent scale-up of viral load testing is critical. The multiple interventions in the healthcare system required to support scale-up of viral load testing are reviewed here. RECENT
FINDINGS: It is estimated that 18.2 million individuals are accessing antiretroviral therapy, consequently this will cause significant demand for viral load monitoring; however, at the current rate of implementation, demand will not meet the required target by 2020. To change this trajectory, multiple stakeholders must be involved, communities and key populations need increased treatment literacy to create demand and greater numbers of healthcare workers will require training. In addition, laboratories and point-of-care testing sites will need to be expanded, and adequate monitoring and evaluation tools will need to be put in place to identify gaps in the system, to institute prompt corrective actions and to direct resources where needed.
SUMMARY: Sufficient scale-up of viral load may well be possible if innovations in mHealth are used to support healthcare workers and patients with regard to the scale-up and effective use of viral load monitoring; new laboratory technologies are implemented, both at a centralized level and point-of-care, to manage higher volumes and improve coverage; and there is careful coordination between implementing partners and funders.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28134713     DOI: 10.1097/COH.0000000000000352

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  17 in total

1.  Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South Africa.

Authors:  Lesley Scott; Anura David; Lara Noble; Matilda Nduna; Pedro Da Silva; Andrew Black; Francois Venter; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

Review 2.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

Authors:  Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

3.  Towards the third 90: improving viral load testing with a simple quality improvement program in health facilities in Malawi.

Authors:  Julie Hubbard; Gift Kakwesa; Mike Nyirenda; James Mwambene; Ashley Bardon; Kelvin Balakasi; Kathryn Dovel; Thokozani Kalua; Risa M Hoffman
Journal:  Int Health       Date:  2019-05-01       Impact factor: 2.473

4.  HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya.

Authors:  Winstone Nyandiko; Sabina Holland; Rachel Vreeman; Allison K DeLong; Akarsh Manne; Vladimir Novitsky; Festus Sang; Celestine Ashimosi; Anthony Ngeresa; Ashley Chory; Josephine Aluoch; Millicent Orido; Eslyne Jepkemboi; Soya S Sam; Angela M Caliendo; Samuel Ayaya; Joseph W Hogan; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2022-02-01       Impact factor: 3.771

5.  Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.

Authors:  Maia Lesosky; Tracy Glass; Elton Mukonda; Nei-Yuan Hsiao; Elaine J Abrams; Landon Myer
Journal:  J Int AIDS Soc       Date:  2017-11       Impact factor: 5.396

6.  HIV viral load monitoring among key populations in low- and middle-income countries: challenges and opportunities.

Authors:  Sheree R Schwartz; Matthew M Kavanagh; Jeremy Sugarman; Sunil S Solomon; Illiassou M Njindam; Kevin Rebe; Thomas C Quinn; Coumba Toure-Kane; Chris Beyrer; Stefan Baral
Journal:  J Int AIDS Soc       Date:  2017-11       Impact factor: 5.396

7.  Results of Early Virologic Monitoring May Facilitate Differentiated Care Monitoring Strategies for Clients on ART, Rakai, Uganda.

Authors:  Victor Ssempijja; Larry W Chang; Gertrude Nakigozi; Anthony Ndyanabo; Thomas C Quinn; Frank Cobelens; Maria Wawer; Ronald Gray; David Serwadda; Steven J Reynolds
Journal:  Open Forum Infect Dis       Date:  2018-10-09       Impact factor: 3.835

8.  Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda: A prospective cohort study.

Authors:  Mastula Nanfuka; Jamie I Forrest; Wendy Zhang; Stephen Okoboi; Josephine Birungi; Pontiano Kaleebu; Julia Zhu; Samuel Tibenganas; David M Moore
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

9.  Association of HIV/AIDS Clinician Warm Line Utilization with Diagnosis and Management of Antiretroviral Treatment Failure in Mozambique: A Retrospective Analysis of Program Data.

Authors:  Maria Ruano Camps; Paula E Brentlinger; Gerito Augusto; Alexandre Nguimfack; Florindo Mudender
Journal:  J Int Assoc Provid AIDS Care       Date:  2017-05-31

10.  Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing.

Authors:  Trevor Peter; Clement Zeh; Zachary Katz; Ali Elbireer; Bereket Alemayehu; Lara Vojnov; Alex Costa; Naoko Doi; Ilesh Jani
Journal:  J Int AIDS Soc       Date:  2017-11       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.